Related Experiment Video
Updated: May 14, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Probiotics: a new frontier for infection control.
1Department of Infection, Barts and The London NHS Trust, Whitechapel, London, UK. Josephine.Seale@bartshealth.nhs.uk
Guidelines are needed to manage infection risks from probiotics, live micro-organisms used for health benefits. Recommendations include stakeholder communication, laboratory identification, and adverse event surveillance to ensure safe clinical use.
Area of Science:
- Microbiology
- Clinical Medicine
- Public Health
Background:
- Probiotics, live micro-organisms conferring health benefits, are increasingly used in clinical settings, including neonatal intensive care.
- Current clinical practice lacks sufficient guidelines and regulations for managing infection risks associated with probiotic use.
Purpose of the Study:
- To address the paucity of guidelines for probiotic use in healthcare.
- To propose actionable recommendations for mitigating infection risks linked to probiotics.
Main Methods:
- Literature review and expert consensus on probiotic safety protocols.
- Development of a framework for risk mitigation strategies.
Main Results:
- Identified critical areas for risk management: stakeholder communication, laboratory capacity, standardization, and surveillance.
- Proposed specific recommendations within these areas to enhance patient safety.
Conclusions:
- Implementing standardized protocols for probiotic preparation, administration, and identification is crucial.
- Enhanced surveillance and clear communication channels are essential for safe probiotic integration into routine healthcare.
Related Concept Videos
Probiotics
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Microorganisms in Medicine and Therapeutics
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Biological Methods for Microbial Control

